Upload
Featured Recent Articles Topics Login Upload

Search Results for 'phase patients'

phase patients published presentations and documents on DocSlides.

August 28, 2022 NCT04304534
August 28, 2022 NCT04304534
by christina
John H. Alexander, MD, MHS. on behalf of the PACIF...
Metabolism, alcohol and toxicity
Metabolism, alcohol and toxicity
by josephine
Best of ILC 2018. About these slides. These slides...
Presenters Biff F. Palmer
Presenters Biff F. Palmer
by della
, MD. Professor of Internal Medicine . UT Southwes...
Blinded Sample Size Re-estimation in a Phase III Study Investigating Progression Free Survival
Blinded Sample Size Re-estimation in a Phase III Study Investigating Progression Free Survival
by naomi
David Morgan (King’s College, London / Consultan...
Clinical Advances in Hematology Oncology Volume 16 Issue 2 Februa
Clinical Advances in Hematology Oncology Volume 16 Issue 2 Februa
by piper
Clinical Advances in Hematology & Oncology Volume...
J Vasc Endovasc Surg 14 170176 1997
J Vasc Endovasc Surg 14 170176 1997
by emily
Doppler Microembolus Detection in the Identificati...
Psychopharmacology in the Medically Ill
Psychopharmacology in the Medically Ill
by Dreamsicle
ACLP Resident Education Curriculum. Revised 2019: ...
Tumor agnostic approvals
Tumor agnostic approvals
by CountryBumpkin
Master trials in practice. Stat4Onc, Hartford CT. ...
Demystifying Clinical Trials: Focusing on Trials with Therapeutic Intent
Demystifying Clinical Trials: Focusing on Trials with Therapeutic Intent
by tabitha
Ashley E. Ross MD PhD. Executive Medical Director....
A New Disease Cluster: Postural Orthostatic Tachycardia Syndrome,
A New Disease Cluster: Postural Orthostatic Tachycardia Syndrome,
by rodriguez
Ehlers-Danlos Syndrome, and . Mast Cell Activation...
DCVax®-L 020221 Phase 3 Clinical Trial
DCVax®-L 020221 Phase 3 Clinical Trial
by cappi
Dendritic Cell Therapy for Brain Cancer. Where Are...
Ehab Sayed Ramadan Addiction Therapy 2015
Ehab Sayed Ramadan Addiction Therapy 2015
by ella
Florida. , USA. August 03-08, 2015. Detoxificatio...
The Northeast ALS Consortium
The Northeast ALS Consortium
by unita
Merit E. Cudkowicz, MD, MSc. Mass General Hospital...
Targeting KRAS G12C  in Solid Tumors
Targeting KRAS G12C  in Solid Tumors
by morton
: . A . New Anticancer Approach  . Marwan Fakih, ...
Clinical Trials: Finding Your Passion for Research
Clinical Trials: Finding Your Passion for Research
by elysha
Shannon Benson, RN, MSN. Administrator. Iowa-Wide ...
Chronic Leukemia and
Chronic Leukemia and
by ash
Multiple Myeloma . Chronic Leuke...
Prevalence of venous sinus stenosis in
Prevalence of venous sinus stenosis in
by lucy
Pseudotumor. cerebri. (PTC) using digital subtrac...
Safety Findings of the Phase I Study of Conivaptan for Cerebral Edema in ICH
Safety Findings of the Phase I Study of Conivaptan for Cerebral Edema in ICH
by isabella
Jesse J. Corry, MD. John Nasseff Neuroscience Spec...
Antibody-based Therapies
Antibody-based Therapies
by osullivan
Dr. John Kuruvilla. Princess Margaret Cancer Centr...
The Acne Landscape Is Evolving
The Acne Landscape Is Evolving
by madeline
This program will include a discussion of data tha...
Rheumatologic disorders The
Rheumatologic disorders The
by caitlin
rheumatic diseases . of . childhood are characteri...
Updated Results From a Phase 2 Study of Pracinostat in Combination Wit
Updated Results From a Phase 2 Study of Pracinostat in Combination Wit
by melody
BACKGROUNDElderly patients with acute myeloid leuk...
2MMWRJune 20 2003It is strongly recommended that patientcentered care
2MMWRJune 20 2003It is strongly recommended that patientcentered care
by singh
Strength of the recommendationAPreferred should ge...
Copyright
Copyright
by mia
2021 Zacks Investment Research All Rights Reserved...
APACITABINE
APACITABINE
by payton
S Winter 2018 - 19 DNA Damage Response (DDR) Prog...
Management Presentation
Management Presentation
by ivy
1 1 January 2017 Jefferies 2017 London Healthcare ...
Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas
Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas
by botgreat
Lisocabtagene. . Maraleucel. in Relapsed/Refract...
by billiontins
2018;36(8):773-9.. Nivolumab Monotherapy (Cohort 1...
by clustik
proceedings from the live CME event and may includ...
Case Discussion
Case Discussion
by breezeibm
Hb. 6.6, platelet count . 17,000. Bone . marrow b...
Cheson B et al. Proc ASH
Cheson B et al. Proc ASH
by pattyhope
2016;Abstract 615; Sehn LH. et al. . Lancet . Onc...
A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide and
A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide and
by scoopulachanel
Myeloma. 1. Safety and Efficacy of Daratumumab wit...
Mature Results from ECOG Study E1405 — A Phase II Study of
Mature Results from ECOG Study E1405 — A Phase II Study of
by webraph
VcR. -CVAD with Maintenance Rituximab for Previous...
Best of ASCO GU Session Sandy Srinivas.MD
Best of ASCO GU Session Sandy Srinivas.MD
by experimentgoogle
Stanford University. Outline. Abstract #4. :. . I...
Romidepsin in Association with CHOP in Patients with Peripheral T
Romidepsin in Association with CHOP in Patients with Peripheral T
by accompanypepsi
-Cell . Lymphoma: Final Results of the Phase . Ib....
Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk
Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk
by cheeserv
Myelodysplastic. Syndromes: Interim Results on Ef...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
NEw developments IN gynecological Oncology
NEw developments IN gynecological Oncology
by cheryl-pisano
highlights from the. EUROPEAN . society . of med...
Overall Survival Benefit of
Overall Survival Benefit of
by tatyana-admore
Obinutuzumab. Over Rituximab when Combined with ...
Challenging Case Study: VTE Treatment- “How Long is Long Enough?”
Challenging Case Study: VTE Treatment- “How Long is Long Enough?”
by olivia-moreira
Thomas W. Butler, M.D., F.A.C.P.. Associate Profe...